Prioritizing HighRisk Patients To promote equity, clinicians should prioritize patients with: Poor glycemic control despite current therapy High BMI and multiple comorbidities Limited access to consistent medical care High cardiovascular risk profiles Establishing clear, data-driven criteria helps remove subjective bias from decision-making and supports fair access
One thing to know about Kojic Acid is that stability is its weak spot
They also talk up supplements and lifestyle practices to reduce cortisol levels
L-glutathione (liposome) 180mg
GLP-1s do seem to quiet the food noise, and some of the survey data from the 102-week studies of GLP-1 use indicate a lot of this reduction in cravings and preoccupation with food remains reduced, though maybe at a slightly lower level than early on in treatment
Patients with type 2 diabetes who are about to begin, or who have recently begun, taking a GLP-1 drug should have a baseline dilated eye examination to determine their level of DR
